The GMP Letter
December 2010
Sepal Is Warned Over Procedures After Its First FDA Inspection
Sepal Reproductive Devices, a Boston-based distributor of reproductive devices and diagnostics, failed to establish a number of written procedures and does not have a PMA or 510(k) for some of its products, according to an FDA warning letter.
This article is viewable by subscribers only. To view this article, please select an option below.
|